Literature DB >> 19053309

Structural and formulation factors influencing pyridinium lipid-based gene transfer.

Lin Zhu1, Yan Lu, Duane D Miller, Ram I Mahato.   

Abstract

A series of pyridinium lipids containing a heterocyclic ring and a nitrogen atom were synthesized to determine the structure-activity relationship for gene delivery. Pyrylium chloroaluminate was synthesized by monoacylation of mesityl oxide and converted into pyrylium hexafluorophosphate, which was used as the key intermediate for reaction with different primary amines, to yield hydroxyethylpyridinium hexafluorophosphate and aminoethylpyridinium hexafluorophosphate. Acylation of these pyridinium salts with different types of fatty acid chlorides afforded the final pyridinium lipids, which were mixed with a co-lipid, such as L-alpha-dioleoylphosphatidylethanolamine (DOPE) and cholesterol (Chol) to prepare cationic liposomes by sonication. These liposomes were mixed with plasmid DNA encoding enhanced green fluorescent protein (pCMS-EGFP) or luciferase (pcDNA3-Luc) and transfected into Chinese hamster ovary (CHO) cells. Several factors including hydrophobic anchor chain length, anchor chain type, configuration of double bond, linker type, co-lipid type, cationic lipid/co-lipid molar ratio, charge ratio (N/P), and cell type had significant influence on transfection efficiency and cytotoxicity. Pyridinium lipids with amide linker showed significantly higher transfection efficiency compared to their ester counterparts. Liposomes prepared at a 1:1 molar ratio of pyridinium lipid and co-lipid showed higher transfection efficiency when either DOPE or cholesterol was used as a co-lipid to prepare cationic liposomes for complex formation with plasmid DNA at 3:1(+/-) charge ratio. Pyridinium liposomes based on a hydrophobic anchor chain length of 16 showed higher transfection efficiency and lower cytotoxicity. The pyridinium lipid with a trans-configuration of the double bond in the fatty acid chain showed higher transfection efficiency than its counterpart with cis-configuration at the same fatty acid chain length. In the presence of serum, C16:0 and Lipofectamine significantly decreased their transfection efficiencies, which were completely lost at a serum concentration of 30% and higher, while C16:1 trans-isomer still had high transfection efficiency under these conditions. In conclusion, pyridinium lipids showed high transfection efficiency and have the potential to be used as transfection reagents in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19053309      PMCID: PMC2681295          DOI: 10.1021/bc8004039

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  43 in total

Review 1.  Phosphatidylethanolamine liposomes: drug delivery, gene transfer and immunodiagnostic applications.

Authors:  D C Litzinger; L Huang
Journal:  Biochim Biophys Acta       Date:  1992-08-14

2.  Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery.

Authors:  I van der Woude; A Wagenaar; A A Meekel; M B ter Beest; M H Ruiters; J B Engberts; D Hoekstra
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Plasmid DNA gene therapy: studies with the human interleukin-2 gene in tumor cells in vitro and in the murine B16 melanoma model in vivo.

Authors:  S E Parker; S Khatibi; M Margalith; D Anderson; M Yankauckas; S H Gromkowski; T Latimer; D Lew; M Marquet; M Manthorpe; P Hobart; E Hersh; A T Stopeck; J Norman
Journal:  Cancer Gene Ther       Date:  1996 May-Jun       Impact factor: 5.987

4.  Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung.

Authors:  E R Lee; J Marshall; C S Siegel; C Jiang; N S Yew; M R Nichols; J B Nietupski; R J Ziegler; M B Lane; K X Wang; N C Wan; R K Scheule; D J Harris; A E Smith; S H Cheng
Journal:  Hum Gene Ther       Date:  1996-09-10       Impact factor: 5.695

5.  Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung.

Authors:  R K Scheule; J A St George; R G Bagley; J Marshall; J M Kaplan; G Y Akita; K X Wang; E R Lee; D J Harris; C Jiang; N S Yew; A E Smith; S H Cheng
Journal:  Hum Gene Ther       Date:  1997-04-10       Impact factor: 5.695

6.  Safety and short-term toxicity of a novel cationic lipid formulation for human gene therapy.

Authors:  H San; Z Y Yang; V J Pompili; M L Jaffe; G E Plautz; L Xu; J H Felgner; C J Wheeler; P L Felgner; X Gao
Journal:  Hum Gene Ther       Date:  1993-12       Impact factor: 5.695

7.  The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer.

Authors:  H Farhood; N Serbina; L Huang
Journal:  Biochim Biophys Acta       Date:  1995-05-04

8.  Efficient transformation of mammalian cells using DNA interpolyelectrolyte complexes with carbon chain polycations.

Authors:  A V Kabanov; I V Astafieva; I V Maksimova; E M Lukanidin; G P Georgiev; V A Kabanov
Journal:  Bioconjug Chem       Date:  1993 Nov-Dec       Impact factor: 4.774

9.  Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes.

Authors:  R I Mahato; K Kawabata; T Nomura; Y Takakura; M Hashida
Journal:  J Pharm Sci       Date:  1995-11       Impact factor: 3.534

10.  Effect of cationic cholesterol derivatives on gene transfer and protein kinase C activity.

Authors:  H Farhood; R Bottega; R M Epand; L Huang
Journal:  Biochim Biophys Acta       Date:  1992-11-09
View more
  8 in total

Review 1.  Subcellular fate and off-target effects of siRNA, shRNA, and miRNA.

Authors:  Saurabh Singh; Ajit S Narang; Ram I Mahato
Journal:  Pharm Res       Date:  2011-10-28       Impact factor: 4.200

2.  Silica nanoparticle supported lipid bilayers for gene delivery.

Authors:  Juewen Liu; Alison Stace-Naughton; C Jeffrey Brinker
Journal:  Chem Commun (Camb)       Date:  2009-07-28       Impact factor: 6.222

Review 3.  Lipid and polymeric carrier-mediated nucleic acid delivery.

Authors:  Lin Zhu; Ram I Mahato
Journal:  Expert Opin Drug Deliv       Date:  2010-10       Impact factor: 6.648

4.  Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation.

Authors:  Lin Zhu; Ram I Mahato
Journal:  Bioconjug Chem       Date:  2010-10-21       Impact factor: 4.774

5.  TGF-beta1 gene silencing for treating liver fibrosis.

Authors:  Kun Cheng; Ningning Yang; Ram I Mahato
Journal:  Mol Pharm       Date:  2009 May-Jun       Impact factor: 4.939

Review 6.  Stimulus-responsive nanopreparations for tumor targeting.

Authors:  Lin Zhu; Vladimir P Torchilin
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

Review 7.  Current progress in gene delivery technology based on chemical methods and nano-carriers.

Authors:  Lian Jin; Xin Zeng; Ming Liu; Yan Deng; Nongyue He
Journal:  Theranostics       Date:  2014-01-15       Impact factor: 11.556

8.  The Impact of Alkyl-Chain Purity on Lipid-Based Nucleic Acid Delivery Systems - Is the Utilization of Lipid Components with Technical Grade Justified?

Authors:  Dorota Pawlowska; Christopher Janich; Andreas Langner; Bodo Dobner; Christian Wölk; Gerald Brezesinski
Journal:  Chemphyschem       Date:  2019-07-23       Impact factor: 3.102

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.